All News
Eyestem announces completion of phase one of its RPE Cell Therapy
The trial evaluates the safety and efficacy of Eyecyte-RPE in patients with geographic atrophy secondary to dry age-related macular degeneration
Read MoreVirohan, Orange Health Labs partner to place medical laboratory technologists across 76 cities
The collaboration aims to offer internships and job opportunities across 76 cities
Read MoreWhy a Vaccine Expert Left the C.D.C.: ‘Americans Are Going to Die’
Dr. Fiona Havers is influential among researchers who study immunizations. The wholesale dismissal of the agency’s scientific advisers crossed the line, she said.
Read MoreWhat Happens if Vaccines Aren’t Recommended?
In recent extraordinary moves, Health Secretary Robert F. Kennedy Jr. has fired and replaced a team that makes vaccine recommendations for the country.
Read MoreAbortion remains a criminal offence in the UK because of the left’s timidity. We must learn from that – and fast | Stella Creasy
Tuesday’s vote in parliament was a missed opportunity – and proof that progressives are allowing the right to shape the key debatesAround the world, the antis are joining forces.
Read MoreNurse Practitioners Critical in Treating Older Adults as Ranks of Geriatricians Shrink
The number of nurse practitioners specializing in geriatrics has more than tripled since 2010.
Read MoreHave Job-Based Health Coverage at 65? You May Still Want To Sign Up for Medicare
Patient advocates say they frequently hear from people who thought they didn’t need to sign up for Medicare when they turned 65 because they had group health coverage.
Read MoreAn Arm and a Leg: The Prescription Drug Playbook, Part I
In Part 1 of a two-part series on dealing with the high price of prescription drugs, a father explains the strategies he used to get his daughter the medicine she needs to treat her epilepsy.
Read MoreWhy a lot of Native American deaths are not counted
Native American deaths are significantly undercounted because of errors in death certificates, a new study claims.
Read MoreSTAT+: Does the FDA commissioner’s new voucher program open a Pandora’s box?
The FDA is setting up a pilot program to review some drugs within one to two months.
Read More